Bay Street News, 2024

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based […]

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional […]

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC) and its […]

SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading […]

MALVERN, Pa., April 12, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused […]

CARLSBAD, Calif., April 12, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (“AppTech”) (NASDAQ: APCX), a pioneering Fintech company powering frictionless […]

WALTHAM, Mass., April 12, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect […]

BEIJING, April 12, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a […]

Herzliya Israel, April 12, 2024 (GLOBE NEWSWIRE) — Beamr (Nasdaq: BMR), a leading supplier of video optimization technology and solutions, […]